| 2026-06-13 16:00 | UU:ASND | | News Release200 | Phase 3 Data Show TransCon(TM) PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism |
| 2026-06-13 12:45 | UU:GMAB | | News Release200 | Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) |
| 2026-06-13 11:15 | UU:LLY | | News Release200 | Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting |
| 2026-06-13 11:15 | UU:INCY | | News Release200 | Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia |
| 2026-06-13 09:00 | UU:AGIO | | News Release200 | Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease |
| 2026-06-13 08:01 | UU:RYTM | | News Release200 | Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 |
| 2026-06-13 07:30 | UU:NTLA | | News Release200 | Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema |
| 2026-06-13 06:33 | UU:JNJ | | News Release200 | New TALVEY(TM) (talquetamab-tgvs) plus DARZALEX FASPRO(TM) (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma |
| 2026-06-13 06:22 | UU:RDY | | News Release200 | Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif(TM), in the United States |
| 2026-06-13 06:00 | UU:INCY | | News Release200 | Results from Incyte's Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi(TM)/Minjuvi(TM)) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival |
| 2026-06-12 22:50 | UU:BTUMF | | News Release200 | BTU Additional Details Regarding Recent Acquisition |
| 2026-06-12 22:32 | UU:SPCX | | News Release200 | Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc. |
| 2026-06-12 22:32 | UU:SPCL | | News Release200 | Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc. |
| 2026-06-12 22:00 | UU:RKDA | | News Release200 | Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules |
| 2026-06-12 21:30 | UU:BLTE | | News Release200 | Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 |
| 2026-06-12 21:25 | UU:EXC | | News Release200 | ComEd Continues Power Restoration Following Two Powerful Storms |
| 2026-06-12 21:24 | UU:DOCKF | | News Release200 | Republic Technologies Inc. Provides Bi-Weekly Update On Annual Filings |
| 2026-06-12 20:00 | UU:ROMA | | News Release200 | ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical |
| 2026-06-12 20:00 | UU:BATXF | | News Release200 | Battery X Metals Appoints Automotive Industry Professional from Canadian Subsidiary of One of the World's Leading Premium Automobile Manufacturers, Headquartered in Munich, Germany, to its Advisory Board to Advance Commercialization of Its Patent-Pending |
| 2026-06-12 19:23 | UU:NUEPF | | News Release200 | NU E Power Corp. Files 2026 First Quarter Results |
| 2026-06-12 19:15 | UU:LMEFF | | News Release200 | Laurion Announces First Tranche Closing Of Private Placement Of Flow-Through Units And Non Flow-Through Shares |
| 2026-06-12 19:01 | UU:TSX | | News Release200 | OpenText to Create 400 Jobs with euros105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe |
| 2026-06-12 19:01 | UU:TSX | | News Release200 | OpenText to Create 400 Jobs with euros105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe |
| 2026-06-12 19:01 | UU:OTEX | | News Release200 | OpenText to Create 400 Jobs with euros105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe |
| 2026-06-12 19:01 | UU:OTEX | | News Release200 | OpenText to Create 400 Jobs with euros105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe |
| 2026-06-12 18:44 | UU:RYOOF | | News Release200 | Rio Silver Announces Results of Annual General Meeting |
| 2026-06-12 18:44 | UU:AZN | | News Release200 | TRUQAP(TM) (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer |
| 2026-06-12 18:35 | UU:UGODF | | News Release200 | Engages Danayi Capital Corp. To Provide Digital Marketing Services |
| 2026-06-12 18:23 | UU:SSPC | | News Release200 | CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand |
| 2026-06-12 18:23 | UU:SPCH | | News Release200 | CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand |
| 2026-06-12 18:20 | UU:WHR | | News Release200 | Whirlpool Announces Cash Tender Offer Early Results |
| 2026-06-12 18:15 | UU:HBPCF | | News Release200 | Helix Biopharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Nine-Month Periods Ended April 30, 2026 |
| 2026-06-12 18:15 | UU:HBPC | | News Release200 | Helix Biopharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Nine-Month Periods Ended April 30, 2026 |
| 2026-06-12 18:14 | UU:CTVFF | | News Release200 | CleanTech Issues Clarification Regarding Qualified Person Disclosure |
| 2026-06-12 18:01 | UU:NZERF | | News Release200 | New Zealand Energy Corp. Provides Corporate Update |
| 2026-06-12 17:45 | UU:MPC | | News Release200 | Marathon Petroleum Named to Dow Jones Best-in-Class Indices |